APHEXDA 62 mg/1.7mL
MOTIXAFORTIDE · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Gamida Cell Inc.
No Recall History
Plain English
APHEXDA is a injection, powder, lyophilized, for solution containing motixafortide at 62 mg/1.7mL, taken subcutaneous. Manufactured by Gamida Cell Inc..
Key Facts
- Brand Name
- APHEXDA
- Generic Name
- MOTIXAFORTIDE
- NDC Code (Product)
73441-062- Manufacturer
- Gamida Cell Inc.
- Strength
- 62 mg/1.7mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA217159
- Marketing Start
- 06/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is APHEXDA used for?
APHEXDA contains MOTIXAFORTIDE. It is a injection, powder, lyophilized, for solution taken subcutaneous. Consult your doctor for specific uses.
Is APHEXDA a controlled substance?
APHEXDA is not classified as a controlled substance by the DEA.
What is the generic name for APHEXDA?
The generic name for APHEXDA is MOTIXAFORTIDE. There are 1 other brand versions of MOTIXAFORTIDE.
What is the NDC code for APHEXDA 62 mg/1.7mL?
The NDC (National Drug Code) for APHEXDA 62 mg/1.7mL is 73441-062, listed by Gamida Cell Inc..